Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Disease-modifying treatments f...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Disease-modifying treatments for Alzheimer's disease: a perspective based on experience with R-Flurbiprofen.
Bibliographic Details
Main Author:
Wilcock, G
Format:
Journal article
Language:
English
Published:
2006
Holdings
Description
Similar Items
Staff View
Similar Items
A Peptide-Based Nanocarrier for an Enhanced Delivery and Targeting of Flurbiprofen into the Brain for the Treatment of Alzheimer’s Disease: An In Vitro Study
by: Shafq Al-azzawi, et al.
Published: (2020-08-01)
Treatment for Alzheimer's disease.
by: Wilcock, G
Published: (2000)
Flurizan, (MPC-7869, (R)-flurbiprofen) a selective A beta-42 lowering agent in patients with mild to moderate Alzheimer's disease: A randomised, placebo-controlled, double blind trial
by: Wilcock, G, et al.
Published: (2005)
Efficacy and safety of MPC-7869 (R-flurbiprofen), a Selective AB42-Lowering Agent, in Alzheimer's disease (AD): Results of a 12-month phase 2 trial and 1-year follow-on study.
by: Laughlin, M, et al.
Published: (2006)
Treatment of the cholinergic impairment in Alzheimer's disease
by: Wilcock, G
Published: (1994)